Comirnaty

🇺🇸 United States

FDA Page

Effective Date: Sep 2, 2026
Approval ID: 48c86164-de07-4041-b9dc-f2b5744714e5
Products: 0 registered
Version: 22

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use COMIRNATY safely and effectively. See full prescribing information for COMIRNATY. COMIRNATY(COVID-19 Vaccine, mRNA) injectable suspension, for intramuscular use2026-2027 FormulaInitial U.S. Approval: 2021

Quick Stats

Total Products0

Labelers0

Label Sections0

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.